Cook Medical Introduces Innovative Aneurysm Therapy Technique In China
This article was originally published in PharmAsia News
Cook Medical recently introduced to Shanghai's major hospitals its innovative aneurysm therapy technique for the surgical treatment of thoracic aorta aneurysms. By inserting a special vascular stent into an aneurysm, the minimally invasive intervention methodology can increase the stability of the surgery. Cook Medical has conducted clinical trials of the technique in German hospitals and results show the therapy can effectively reduce the rate of blood vessel rupture, lowering patient death incidence. At present, China has about 100,000 thoracic aorta aneurysm patients, of whom fewer than 100 get treated. (Click here for more - Chinese Language)
You may also be interested in...
Office of New Drugs Director Peter Stein said in an interview that a large amount of coronavirus-related work is arriving at the FDA, but so far staff are keeping up.
Akero’s FGF21 analog yields 63%-72% relative hepatic fat reduction in Phase IIa study; the company awaits biopsy data hoping to see a fibrotic benefit. Also, Genfit says COVID-19 pandemic should not significantly delay its Phase III NASH readout.
US Vice President Mike Pence and Medicare administrator Seema Verma want academic and university hospital laboratories to send their de-identified COVID-19 test data results, daily, to the Department of Health and Human Services. Commercial and private labs are exempt from the request, as they already share their coronavirus test results with the government.